Zai Lab Limited

Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

ZLAB Nasdaq ISIN KYG9887T1168 SEC CIK 1704292 LEI 549300P2UYQ9U5LY1T58
Follow Zai Lab Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $107.6M −6.7% vs same quarter last year
Net income −$46.1M −28.3% vs same quarter last year
EPS, diluted −$0.04 −33.3% vs same quarter last year
Operating cash flow −$57.9M −80.6% vs same quarter last year
Revenue by quarter
$108.5M
$105.7M
$109.1M
$115.4M
$127.1M
$95.6M
$105.8M
$107.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$1B−$500M$0$500MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$457.2M−$175.5M
FY24$397.6M−$257.1M
FY23$266.7M−$334.6M
FY22$212.7M−$443.3M
FY21$144.1M−$704.5M
FY20$49M−$268.9M
FY19$13M−$195.1M
FY18$129K−$139.1M
FY17-−$50.4M
FY16-−$37.5M
FY15-−$18M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150000%−100000%−50000%0%50000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2558.3%−50.2%−38.4%
FY2463%−71%−64.7%
FY2364.1%−137.4%−125.5%
FY2265.2%−190.1%−208.4%
FY2163.7%−485.8%−488.9%
FY2065.8%−616.4%−549.3%
FY1971.1%−1564.9%−1502.3%
FY1866.6%−109897.7%−107810.1%
FY17---
FY16---
FY15---
FY14---
Free cash flowOperating cash flow minus capital expenditure
−$600M−$400M−$200M$0FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$158.9M
FY24−$220.5M
FY23−$205.4M
FY22−$392.2M
FY21−$567.5M
FY20−$226.2M
FY19−$197M
FY18−$107.6M
FY17−$41.5M
FY16−$34.4M
FY15−$12.2M
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Zai Lab
  • Healthcare median
−150000%−100000%−50000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearZai LabHealthcare median
FY25−38.4%−30.6%
FY24−64.7%−47%
FY23−125.5%−58%
FY22−208.4%−80.4%
FY21−488.9%−71.9%
FY20−549.3%−62.2%
FY19−1502.3%−46.3%
FY18−107810.1%−49.6%
FY17-−45.9%
FY16-−36%
FY15-−38.4%
FY14-−35.5%